← All candidates
One insider bought $286.6K in a single day.
10 filings on record.
INBXInhibrx Biosciences, Inc.
NasdaqGS · Healthcare · $1.50B
$101.77
-3.64% · Sep 16
One insider bought $286.6K in a single day.
Led by Forsyth Douglas, director.
Price · 1Y · daily● 1 buy● 5 sells◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.50B
Float
8.6M
58% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Forsyth Douglas
Bought $286.6K on Sep 8 — 2,500 sh @ $114.65, held indirect, 1.1% of their stake.
First Form 4 on file
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
3 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
1 more transaction on Pro →Context
Wall St
$266.67 avg target
+162.0% vs today · 3 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q2 '26−$2.34 act−$0.06
Q1 '26−$2.15 act−$0.95
Q4 '25−$2.11 act−$0.03
Q3 '25−$2.28 act−$0.56
Coverage
Inhibrx Shares Rise After Positive Phase 2 Head and Neck Cancer DataInvestorsHub · 1w agoAre You Looking for a Top Momentum Pick? Why Inhibrx Biosciences, Inc. (INBX) is a Great ChoiceZacks · 07-09Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon StudyInsider Monkey · 05-14Should Positive INBRX-106 Phase 2 Head and Neck Data Require Action From Inhibrx Biosciences (INBX) Investors?Simply Wall St. · 05-12
The file stays open
10 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice